Format

Send to

Choose Destination
See comment in PubMed Commons below
J Acquir Immune Defic Syndr. 2012 Aug 1;60 Suppl 2:S39-40. doi: 10.1097/QAI.0b013e318258bc9f.

The future of HIV treatment.

Author information

1
Department of Medicine, Massachusetts General Hospital, Boston MA, USA. hirsch.martin@mgh.harvard.edu

Abstract

Antiretroviral therapy has transformed the management of HIV-infected individuals over the past quarter century. However, important challenges remain. These include attempts to eradicate HIV from reservoirs within the body, thereby eliminating the need for lifetime therapy. In addition, improvements in drug development, clinical trial, and regulatory pathways are necessary to expeditiously evaluate novel therapeutic regimens and strategies. Antiretroviral drug scarcity remains a major problem in underserved populations worldwide, and partnerships among pharmaceutical companies, academic investigators, and both governmental and nongovernmental agencies are necessary to improve access to these life-saving regimens.

PMID:
22772389
PMCID:
PMC3404730
DOI:
10.1097/QAI.0b013e318258bc9f
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wolters Kluwer Icon for PubMed Central
    Loading ...
    Support Center